About Blood & Treasure
We’ve worked on the other side of the pitch.
Since 2015, we’ve helped startups build software in NYC. We bring that experience to building research and screening systems for investment teams.
We built a screening tool for Ardabelle Capital that assesses deal documents against its investment criteria and produces a short memo with supporting sources.
Startups we’ve worked with
Rep’d
- $300K pre-seed
Thnks
- $3.8M seed
Dollaride
- $1M seed
- $10M award
Liquid Talent
- $1.3M seed
Altru
- $60M exit
Yoke Payments
- $500K seed
Avvir
- $200K pre-seed
Sportego
- $150K pre-seed
Our experience
From first product to what comes next.
Startups we’ve worked with have secured funding, won awards and achieved exits totaling more than $75 million. That experience shapes the questions we ask.
We’ve seen how product decisions, sales cycles and dependencies affect a founder’s plan.
What guides the read
Evidence before conviction.
Your lens
Criteria come first.
We assess fit against your mandate, not a generic startup score.
Clear reasoning
Show the working.
Distinguish the founder’s claims, supporting evidence and our interpretation.
Your decision
Leave room for doubt.
Name what’s missing and what could change the conclusion. Your team makes the investment call.
The exclusions and sustainability requirements we’ve built at Ardabelle are critical to both our value creation and to our reporting transparency. Rigor and speed are typically a trade-off. With this AI tool, we get both.
Cara Kennedy-Cuomo
Founding Partner, Ardabelle Capital
Where does screening slow your team down?
Tell us how you assess deals today. We’ll agree a focused free pilot to test whether Deal Read can help.